How will the EU Joint Clinical Assessment (JCA) reshape healthcare decision-making across Europe?
Join us for an exclusive live panel discussion with national payer specialists from key European countries and Simon-Kucher’s EU JCA expert team as we discuss the evolving landscape of the EU JCA and explore how this regulation will shape the EU healthcare ecosystem, impacting outcomes, processes, and collaborations across stakeholders.
With the JCA process now officially gone into effect, and the HTA Coordination Group releasing key guidance over the past year, this session offers a unique opportunity to explore the challenges, opportunities, and transformative impact of this regulation.
This live discussion will cover:
- Expected Outcomes of EU JCA: Learn what stakeholders anticipate from the new process and how it is expected to pharmaceutical products' assessment across Europe.
- Challenges and Opportunities: Understand the key hurdles in implementing the JCA and identify opportunities for innovation and improvement.
- Country-Specific Adaptations: Discover how different Member States are preparing for and responding to the JCA requirements.
- Expert Perspectives: Hear directly from payer experts who are at the forefront of these changes, offering unparalleled insights into the future of healthcare assessment.
This event is free of charge. Don’t miss this opportunity to gain valuable insights into how EU healthcare is transforming under the JCA process.
